Corcept Therapeutics (CORT) Short Interest Ratio & Short Volume $70.57 +0.97 (+1.39%) Closing price 06/9/2025 04:00 PM EasternExtended Trading$71.48 +0.91 (+1.29%) As of 08:27 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Corcept Therapeutics Short Interest DataCorcept Therapeutics (CORT) has a short interest of 12.48 million shares, representing 13.31% of the float (the number of shares available for trading by the public). This marks a -5.31% decrease in short interest from the previous month. The short interest ratio (days to cover) is 7.7, indicating that it would take 7.7 days of the average trading volume of 1.15 million shares to cover all short positions.Current Short Interest12,480,000 sharesPrevious Short Interest13,180,000 sharesChange Vs. Previous Month-5.31%Dollar Volume Sold Short$915.53 millionShort Interest Ratio7.7 Days to CoverLast Record DateMay 15, 2025Outstanding Shares106,045,000 sharesFloat Size93,770,000 sharesShort Percent of Float13.31%Today's Trading Volume1,064,618 sharesAverage Trading Volume1,145,246 sharesToday's Volume Vs. Average93% Short Selling Corcept Therapeutics? Sign up to receive the latest short interest report for Corcept Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCORT Short Interest Over TimeCORT Days to Cover Over TimeCORT Percentage of Float Shorted Over Time Corcept Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/202512,480,000 shares $915.53 million -5.3%13.3%7.7 $73.36 4/30/202513,180,000 shares $947.38 million +7.2%14.1%8.2 $71.88 4/15/202512,290,000 shares $855.26 million -25.7%13.2%7.9 $69.59 3/31/202516,530,000 shares $1.89 billion +1.2%17.7%11.5 $114.22 3/15/202516,330,000 shares $914.64 million +1.8%17.5%16.2 $56.01 2/28/202516,040,000 shares $971.70 million +4.2%17.2%16.2 $60.58 2/15/202515,390,000 shares $1.12 billion -2.7%16.7%17.5 $72.72 1/31/202515,810,000 shares $1.06 billion -2.8%17.6%18.2 $66.92 1/15/202516,260,000 shares $874.46 million +1.9%18.0%17.6 $53.78 12/31/202415,960,000 shares $804.22 million +1.5%17.7%16.7 $50.39 Get the Latest News and Ratings for CORT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Corcept Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/15/202415,720,000 shares $870.89 million -7.8%17.4%15.9 $55.40 11/30/202417,050,000 shares $983.44 million -7.0%18.9%17.1 $57.68 11/15/202418,340,000 shares $950.56 million -2.5%20.3%18.8 $51.83 10/31/202418,800,000 shares $920.64 million -9.1%20.8%20.7 $48.97 10/15/202420,680,000 shares $968.65 million -3.9%23.0%22.8 $46.84 9/30/202421,510,000 shares $995.48 million -0.9%23.9%25.4 $46.28 9/15/202421,710,000 shares $827.37 million -1.7%24.1%25.4 $38.11 8/31/202422,090,000 shares $779.78 million +2.3%24.6%24.5 $35.30 8/15/202421,590,000 shares $754.35 million -3.0%24.0%21.2 $34.94 7/31/202422,260,000 shares $860.79 million -2.2%24.8%20.2 $38.67 7/15/202422,750,000 shares $735.96 million +4.0%25.3%19.6 $32.35 6/30/202421,880,000 shares $710.88 million +3.0%24.4%19 $32.49 6/15/202421,250,000 shares $615.61 million +10.2%23.7%18.6 $28.97 5/31/202419,290,000 shares $581.98 million -2.6%21.5%17.9 $30.17 5/15/202419,800,000 shares $551.03 million No Change22.1%19.4 $27.83 4/30/202419,800,000 shares $461.74 million -6.3%22.1%18 $23.32 4/15/202421,120,000 shares $488.93 million -1.0%23.7%17.5 $23.15 3/31/202421,330,000 shares $537.30 million +5.5%23.9%15 $25.19 3/15/202420,220,000 shares $469.71 million +1.8%22.7%13 $23.23 2/29/202419,860,000 shares $466.71 million +1.1%22.3%13.1 $23.50 2/15/202419,640,000 shares $480.39 million +1.7%22.0%13.4 $24.46 1/31/202419,320,000 shares $407.65 million +23.3%22.0%14.4 $21.10 1/15/202415,670,000 shares $363.54 million +1.8%17.8%13.2 $23.20 12/31/202315,390,000 shares $499.87 million +0.9%17.5%17 $32.48 12/15/202315,260,000 shares $453.99 million -0.8%17.4%19.6 $29.75 11/30/202315,380,000 shares $391.73 million +0.7%17.5%21.2 $25.47 11/15/202315,270,000 shares $387.55 million +8.1%17.4%20.6 $25.38 10/31/202314,120,000 shares $396.49 million -5.6%16.1%19.4 $28.08 10/15/202314,960,000 shares $412.30 million -0.1%17.1%20 $27.56 9/30/202314,970,000 shares $407.86 million +3.4%17.1%20.8 $27.25Banks aren’t ready for this altcoin—are you? (Ad)While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly positioning itself to overthrow the entire banking system.Click here to access the full report now. 9/15/202314,480,000 shares $484.65 million -2.2%16.6%24.1 $33.47 8/31/202314,800,000 shares $484.40 million -0.5%17.0%23.7 $32.73 8/15/202314,870,000 shares $460.38 million -1.3%17.1%23.9 $30.96 7/31/202315,070,000 shares $383.98 million -4.2%17.3%23.9 $25.48 7/15/202315,730,000 shares $358.96 million -1.1%18.2%27.3 $22.82 6/30/202315,910,000 shares $354.00 million -5.1%18.4%25.2 $22.25 6/15/202316,770,000 shares $388.90 million +0.2%19.2%21.6 $23.19 5/31/202316,730,000 shares $392.99 million -2.3%19.2%20.9 $23.49 5/15/202317,130,000 shares $412.15 million No Change19.6%19.2 $24.06 10/31/202217,050,000 shares $487.63 million -0.8%18.3%30.1 $28.60 10/15/202217,190,000 shares $467.91 million -0.8%18.6%30.8 $27.22 9/30/202217,330,000 shares $444.34 million +1.5%18.7%29.7 $25.64 9/15/202217,070,000 shares $431.87 million -1.6%18.5%26.7 $25.30 8/31/202217,350,000 shares $447.98 million -1.0%18.8%27 $25.82 8/15/202217,530,000 shares $492.07 million -2.2%19.0%25.6 $28.07 7/31/202217,930,000 shares $513.87 million +1.1%19.0%22.4 $28.66 7/15/202217,730,000 shares $482.97 million -1.8%18.8%21.5 $27.24 6/30/202218,060,000 shares $429.47 million -0.6%17.5%20.5 $23.78 6/15/202218,170,000 shares $383.39 million -5.6%17.6%19.8 $21.10 5/31/202219,240,000 shares $400.96 million -5.2%20.4%20.1 $20.84 5/15/202220,300,000 shares $384.48 million +12.0%21.5%20.6 $18.94 4/30/202218,130,000 shares $389.98 million +9.5%19.2%18.7 $21.51 4/15/202216,560,000 shares $405.55 million +2.8%17.6%17.5 $24.49 3/31/202216,110,000 shares $362.80 million -2.8%N/A18 $22.52 3/15/202216,570,000 shares $397.68 million +2.3%17.6%16.7 $24.00 2/28/202216,200,000 shares $361.10 million -0.9%17.1%9.6 $22.29 2/15/202216,340,000 shares $331.87 million -10.2%17.2%9.5 $20.31 1/31/202218,190,000 shares $341.43 million -5.2%17.6%10.5 $18.77 1/15/202219,180,000 shares $353.87 million +13.3%18.5%11.3 $18.45 12/31/202116,930,000 shares $335.21 million -12.9%16.3%10.2 $19.80 12/15/202119,440,000 shares $375.19 million +116.0%18.8%12.5 $19.30 11/30/20219,000,000 shares $189 million +0.5%8.7%9.8 $21.00 11/15/20218,960,000 shares $205.09 million -2.9%8.7%14.8 $22.89 10/29/20219,230,000 shares $166.14 million +9.9%8.9%17.9 $18.00 10/15/20218,400,000 shares $168.34 million -0.7%8.1%17.2 $20.04 9/30/20218,460,000 shares $166.49 million +0.8%8.1%17.5 $19.68 9/15/20218,390,000 shares $171.41 million +1.0%8.1%17 $20.43 8/31/20218,310,000 shares $176.84 million +3.1%8.0%15.8 $21.28 8/13/20218,060,000 shares $166.68 million +2.3%7.7%15.2 $20.68 7/30/20217,880,000 shares $163.67 million +3.1%7.6%13.3 $20.77 7/15/20217,640,000 shares $155.55 million -5.2%7.3%13.6 $20.36 6/30/20218,060,000 shares $177.32 million -18.5%7.7%14.4 $22.00 6/15/20219,890,000 shares $216.89 million -2.9%9.4%17.8 $21.93 5/28/202110,180,000 shares $219.89 million +3.0%9.7%19.9 $21.60 5/14/20219,880,000 shares $206.69 million -1.7%9.4%17.7 $20.92 4/30/202110,050,000 shares $235.77 million -5.4%9.6%17.5 $23.46 4/15/202110,620,000 shares $243.73 million +1.4%N/A0 $22.95 3/31/202110,470,000 shares $245.94 million -2.9%9.9%18 $23.49 3/15/202110,780,000 shares $276.94 million -0.2%10.2%17.6 $25.69 2/26/202110,800,000 shares $276.05 million No Change10.2%16.5 $25.56Banks aren’t ready for this altcoin—are you? (Ad)While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly positioning itself to overthrow the entire banking system.Click here to access the full report now. 2/12/202110,800,000 shares $309.64 million -4.7%10.3%13.6 $28.67 1/29/202111,330,000 shares $325.28 million -4.1%10.9%12.9 $28.71 1/15/202111,810,000 shares $326.19 million -0.7%11.3%12.9 $27.62 12/31/202011,890,000 shares $311.16 million -7.7%11.4%12.9 $26.17 12/15/202012,880,000 shares $330.37 million -6.1%12.3%13.5 $25.65 11/30/202013,720,000 shares $315.42 million -17.1%13.1%11.2 $22.99 11/15/202016,540,000 shares $299.21 million -5.7%15.8%5.7 $18.09 10/30/202017,530,000 shares $300.81 million -6.7%16.7%6.4 $17.16 10/15/202018,780,000 shares $345.18 million -1.4%18.0%6.6 $18.38 9/30/202019,040,000 shares $331.39 million +1.0%18.3%6.7 $17.41 9/15/202018,860,000 shares $334.20 million -18.6%18.1%6.5 $17.72 8/31/202023,160,000 shares $294.13 million +2.8%22.2%8.3 $12.70 8/14/202022,520,000 shares $310.10 million +1.9%21.6%21.2 $13.77 7/31/202022,100,000 shares $330.40 million -1.3%21.2%20.7 $14.95 7/15/202022,380,000 shares $365.02 million -1.2%21.7%22.8 $16.31 6/30/202022,650,000 shares $380.97 million +1.9%21.9%23.2 $16.82 6/15/202022,230,000 shares $338.56 million +1.0%21.5%22 $15.23 CORT Short Interest - Frequently Asked Questions What is Corcept Therapeutics' current short interest? Short interest is the volume of Corcept Therapeutics shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 12,480,000 shares of CORT short. 13.31% of Corcept Therapeutics' shares are currently sold short. Learn More on Corcept Therapeutics' current short interest. What is a good short interest ratio for Corcept Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CORT shares currently have a short interest ratio of 8.0. Learn More on Corcept Therapeutics's short interest ratio. Which institutional investors are shorting Corcept Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Corcept Therapeutics: Jane Street Group LLC, Millennium Management LLC, Caption Management LLC, Nomura Holdings Inc., Twin Tree Management LP, HAP Trading LLC, Walleye Trading LLC, Walleye Capital LLC, Persistent Asset Partners Ltd, and Citigroup Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Corcept Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 13.31% of Corcept Therapeutics' floating shares are currently sold short. Is Corcept Therapeutics' short interest increasing or decreasing? Corcept Therapeutics saw a decrease in short interest in May. As of May 15th, there was short interest totaling 12,480,000 shares, a decrease of 5.3% from the previous total of 13,180,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Corcept Therapeutics' float size? Corcept Therapeutics currently has issued a total of 106,045,000 shares. Some of Corcept Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Corcept Therapeutics currently has a public float of 93,770,000 shares. How does Corcept Therapeutics' short interest compare to its competitors? 13.31% of Corcept Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Corcept Therapeutics: Royalty Pharma plc (6.23%), Jazz Pharmaceuticals plc (10.13%), Perrigo Company plc (3.42%), Supernus Pharmaceuticals, Inc. (7.89%), Pacira BioSciences, Inc. (13.14%), Omeros Co. (19.13%), Nektar Therapeutics (5.94%), Assembly Biosciences, Inc. (0.65%), Cumberland Pharmaceuticals Inc. (0.95%), Eli Lilly and Company (0.87%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($29.20 billion), Strategy Incorporated ($10.88 billion), iShares 20+ Year Treasury Bond ETF ($10.04 billion), Capital One Financial Co. ($5.51 billion), Charter Communications, Inc. ($5.00 billion), Super Micro Computer, Inc. ($4.43 billion), Apollo Global Management, Inc. ($4.02 billion), Hims & Hers Health, Inc. ($3.65 billion), VanEck Semiconductor ETF ($3.27 billion), and Coinbase Global, Inc. ($3.10 billion). View all of the most shorted stocks. What does it mean to sell short Corcept Therapeutics stock? Short selling CORT is an investing strategy that aims to generate trading profit from Corcept Therapeutics as its price is falling. CORT shares are trading up $0.97 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Corcept Therapeutics? A short squeeze for Corcept Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CORT, which in turn drives the price of the stock up even further. How often is Corcept Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CORT, twice per month. The most recent reporting period available is May, 15 2025. More Short Interest Resources from MarketBeat Related Companies Royalty Pharma Short Squeeze Jazz Pharmaceuticals Short Squeeze Perrigo Short Squeeze Supernus Pharmaceuticals Short Squeeze Pacira BioSciences Short Squeeze Omeros Short Squeeze Nektar Therapeutics Short Squeeze Assembly Biosciences Short Squeeze Cumberland Pharmaceuticals Short Squeeze Eli Lilly and Company Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CORT) was last updated on 6/10/2025 by MarketBeat.com Staff From Our PartnersTrump’s Wealth Reset: Could You Be The First Beneficiary?Trump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsA major regulatory shift is scheduled to take effect this July — and it could have serious implications for yo...Monetary Gold | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Imagine you're driving down I-45 between Dallas and Houston. You come up behind an 18-wheeler, flick your s...Weiss Ratings | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredWhy 2026 will be a disaster for many Americans2025 Market Crash The first-quarter stock crash left investors wondering what lies ahead. Today 50-year Wal...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Corcept Therapeutics Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Corcept Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CORT Stock Free CORT Stock Alerts